O	0	15	Characteristics
O	16	18	of
B-Symptom	19	23	disc
I-Symptom	24	34	hemorrhage
O	35	37	in
B-Disease	38	45	primary
I-Disease	46	51	angle
I-Disease	51	52	-
I-Disease	52	59	closure
I-Disease	60	68	glaucoma
O	68	69	.

O	71	73	To
O	74	81	analyze
O	82	85	the
O	86	101	characteristics
O	102	104	of
B-Symptom	105	109	disc
I-Symptom	110	120	hemorrhage
O	121	123	in
B-Disease	124	131	primary
I-Disease	132	137	angle
I-Disease	137	138	-
I-Disease	138	145	closure
I-Disease	146	154	glaucoma
O	155	156	(
B-Disease	156	160	PACG
O	160	161	)
O	161	162	.

O	163	176	Retrospective
O	177	191	noncomparative
O	192	196	case
O	197	203	series
O	203	204	.

O	205	213	Patients
O	214	218	seen
O	219	221	in
B-Disease	222	230	glaucoma
O	231	238	clinics
O	239	243	with
B-Disease	244	248	PACG
O	249	252	and
O	253	254	a
O	255	262	history
O	263	265	of
B-Symptom	266	270	disc
I-Symptom	271	281	hemorrhage
O	281	282	.

B-Diagnostic_tool	283	291	Goldmann
I-Diagnostic_tool	292	301	tonometry
O	301	302	,
B-Diagnostic_tool	303	313	gonioscopy
O	313	314	,
B-Diagnostic_tool	315	329	ophthalmoscopy
O	329	330	,
O	331	334	and
B-Diagnostic_tool	335	344	automated
I-Diagnostic_tool	345	354	perimetry
O	354	355	.

B-Characteristic	356	364	Location
I-Characteristic	364	365	,
I-Characteristic	366	372	number
I-Characteristic	373	375	of
I-Characteristic	376	384	episodes
I-Characteristic	384	385	,
I-Characteristic	386	389	and
I-Characteristic	390	398	duration
I-Characteristic	399	401	of
I-Characteristic	402	406	disc
I-Characteristic	407	417	hemorrhage
O	417	418	;
O	419	429	comparison
O	430	432	of
B-Characteristic	433	444	intraocular
I-Characteristic	445	453	pressure
O	454	455	(
B-Characteristic	455	458	IOP
O	458	459	)
O	460	463	and
B-Characteristic	464	467	cup
I-Characteristic	467	468	-
I-Characteristic	468	470	to
I-Characteristic	470	471	-
I-Characteristic	471	475	disc
I-Characteristic	476	481	ratio
O	482	483	(
B-Characteristic	483	486	CDR
O	486	487	)
O	488	490	in
B-Anatomy	491	495	eyes
O	496	500	with
O	501	504	and
O	505	511	fellow
B-Anatomy	512	516	eyes
O	517	524	without
B-Symptom	525	535	hemorrhage
O	535	536	;
O	537	540	and
O	541	548	changes
O	549	551	of
B-Characteristic	552	555	CDR
O	556	559	and
B-Characteristic	560	566	visual
I-Characteristic	567	573	fields
O	574	575	(
B-Characteristic	575	578	VFs
O	578	579	)
O	580	582	on
O	583	589	follow
O	589	590	-
O	590	592	up
O	592	593	.

O	594	597	The
O	598	602	mean
O	603	611	duration
O	612	614	of
O	615	621	follow
O	621	622	-
O	622	624	up
O	625	628	was
O	629	632	109
O	632	633	.
O	633	634	2
O	634	635	+
O	635	636	/
O	636	637	-
O	637	639	63
O	640	646	months
O	647	648	(
O	648	653	range
O	653	654	,
O	655	656	7
O	656	657	-
O	657	660	261
O	660	661	)
O	661	662	.

O	663	665	Of
O	666	669	770
O	670	678	patients
O	679	683	with
B-Disease	684	688	PACG
O	688	689	,
O	690	692	44
O	693	694	(
O	694	695	5
O	695	696	.
O	696	697	7
O	697	698	%
O	698	699	)
O	700	703	had
B-Symptom	704	708	disc
I-Symptom	709	719	hemorrhage
O	720	722	at
O	723	727	some
O	728	733	point
O	734	736	in
O	737	742	their
O	743	750	history
O	750	751	,
O	752	754	of
O	755	759	whom
O	760	762	30
O	763	764	(
O	764	766	68
O	766	767	%
O	767	768	)
O	769	772	had
O	773	783	unilateral
O	784	787	and
O	788	790	14
O	791	792	(
O	792	794	32
O	794	795	%
O	795	796	)
O	797	800	had
B-Symptom	801	810	bilateral
I-Symptom	811	822	hemorrhages
O	822	823	,
O	824	830	either
O	831	842	alternately
O	843	845	or
O	846	860	simultaneously
O	861	863	in
O	864	868	both
B-Anatomy	869	873	eyes
O	873	874	.

O	875	880	There
O	881	885	were
O	886	887	a
O	888	893	total
O	894	896	of
O	897	900	111
B-Symptom	901	912	hemorrhages
O	913	915	in
O	916	918	58
B-Anatomy	919	923	eyes
O	923	924	,
O	925	934	including
O	935	937	23
B-Anatomy	938	942	eyes
O	943	944	(
O	944	946	40
O	946	947	%
O	947	948	)
O	949	953	with
B-Symptom	954	963	recurrent
I-Symptom	964	975	hemorrhages
O	975	976	.

O	977	979	Of
O	980	983	the
O	984	987	111
O	988	993	total
B-Symptom	994	1005	hemorrhages
O	1005	1006	,
O	1007	1009	85
O	1010	1011	(
O	1011	1013	77
O	1013	1014	%
O	1014	1015	)
O	1016	1024	occurred
O	1025	1027	in
O	1028	1031	the
B-Anatomy	1032	1046	inferotemporal
I-Anatomy	1047	1050	and
I-Anatomy	1051	1053	19
I-Anatomy	1054	1055	(
I-Anatomy	1055	1057	17
I-Anatomy	1057	1058	%
I-Anatomy	1058	1059	)
I-Anatomy	1060	1062	in
I-Anatomy	1063	1066	the
I-Anatomy	1067	1081	superotemporal
I-Anatomy	1082	1088	sector
I-Anatomy	1089	1091	of
I-Anatomy	1092	1095	the
I-Anatomy	1096	1100	disc
O	1100	1101	.

O	1102	1107	Among
O	1108	1110	23
B-Anatomy	1111	1115	eyes
O	1116	1120	with
B-Symptom	1121	1130	recurrent
I-Symptom	1131	1135	disc
I-Symptom	1136	1147	hemorrhages
O	1147	1148	,
O	1149	1151	11
O	1152	1153	(
O	1153	1155	48
O	1155	1156	%
O	1156	1157	)
O	1158	1161	had
O	1162	1172	recurrence
O	1173	1175	in
O	1176	1179	the
O	1180	1184	same
O	1185	1191	sector
O	1192	1194	of
O	1195	1198	the
B-Anatomy	1199	1203	disc
O	1203	1204	.

O	1205	1208	The
O	1209	1216	average
O	1217	1225	duration
O	1226	1228	of
B-Symptom	1229	1240	hemorrhages
O	1241	1244	was
O	1245	1247	12
O	1247	1248	.
O	1248	1249	8
O	1249	1250	+
O	1250	1251	/
O	1251	1252	-
O	1252	1253	8
O	1253	1254	.
O	1254	1255	1
O	1256	1261	weeks
O	1261	1262	.

O	1263	1266	The
B-Characteristic	1267	1270	IOP
O	1271	1274	and
B-Characteristic	1275	1278	CDR
O	1279	1282	did
O	1283	1286	not
O	1287	1293	differ
O	1294	1307	significantly
O	1308	1315	between
B-Anatomy	1316	1320	eyes
O	1321	1325	with
O	1326	1329	and
O	1330	1336	fellow
B-Anatomy	1337	1341	eyes
O	1342	1349	without
B-Symptom	1350	1360	hemorrhage
O	1360	1361	.

O	1362	1365	For
O	1366	1374	patients
O	1375	1379	with
B-Symptom	1380	1390	unilateral
I-Symptom	1391	1395	disc
I-Symptom	1396	1406	hemorrhage
O	1406	1407	,
O	1408	1419	progressive
O	1420	1427	changes
O	1428	1430	in
O	1431	1434	the
B-Characteristic	1435	1438	CDR
O	1439	1443	were
O	1444	1449	found
O	1450	1452	in
O	1453	1457	both
O	1458	1461	the
B-Anatomy	1462	1466	eyes
O	1467	1471	with
O	1472	1475	and
O	1476	1482	fellow
B-Anatomy	1483	1487	eyes
O	1488	1495	without
B-Symptom	1496	1500	disc
I-Symptom	1501	1511	hemorrhage
O	1511	1512	,
O	1513	1516	but
B-Symptom	1517	1519	VF
I-Symptom	1520	1527	defects
O	1528	1536	worsened
O	1537	1541	only
O	1542	1544	in
B-Anatomy	1545	1549	eyes
O	1550	1554	with
B-Symptom	1555	1559	disc
I-Symptom	1560	1570	hemorrhage
O	1570	1571	.

O	1572	1575	The
O	1576	1585	incidence
O	1586	1588	of
B-Symptom	1589	1593	disc
I-Symptom	1594	1604	hemorrhage
O	1605	1607	in
O	1608	1616	patients
O	1617	1621	with
B-Disease	1622	1626	PACG
O	1627	1630	was
O	1631	1632	5
O	1632	1633	.
O	1633	1634	7
O	1634	1635	%
O	1636	1640	over
O	1641	1642	9
O	1643	1648	years
O	1649	1651	of
O	1652	1658	follow
O	1658	1659	-
O	1659	1661	up
O	1661	1662	.

O	1663	1670	Despite
O	1671	1674	its
O	1675	1683	relative
O	1684	1695	infrequency
O	1695	1696	,
B-Symptom	1697	1701	disc
I-Symptom	1702	1712	hemorrhage
O	1713	1715	in
B-Disease	1716	1720	PACG
O	1721	1724	was
O	1725	1735	associated
O	1736	1740	with
B-Symptom	1741	1752	progression
I-Symptom	1753	1755	of
I-Symptom	1756	1768	glaucomatous
I-Symptom	1769	1774	optic
I-Symptom	1775	1785	neuropathy
O	1786	1789	and
B-Symptom	1790	1792	VF
I-Symptom	1793	1800	defects
O	1800	1801	.
